In vitro bleeding test--a simple method for the detection of aspirin effects on platelet function

Area of Science:

• Pharmacology
• Hematology
• Clinical Medicine

Background:

• Aspirin is widely used for its antiplatelet effects.
• Monitoring aspirin's efficacy, especially at low doses, is crucial for preventing thromboembolic disorders.
• Existing platelet function tests vary in sensitivity and practicality.

Purpose of the Study:

• To evaluate platelet function after single and multiple low doses of aspirin.
• To assess the sensitivity of a novel in vitro bleeding test (Thrombostat) for detecting aspirin's effects.
• To determine the duration of aspirin's antiplatelet activity.

Main Methods:

• 21 healthy donors received single oral doses of aspirin (0.02g to 1.0g).
• 3 additional donors received daily 0.02g aspirin for 5 days.
• Platelet function was assessed using a new whole blood in vitro bleeding test (Thrombostat) and compared to other standard tests.

Main Results:

• The Thrombostat assay was more sensitive than conventional tests in detecting aspirin's effects.
• Significant increases in in vitro bleeding volumes were observed for at least 2 days after 0.1g to 1.0g aspirin doses.
• Aspirin's antiplatelet effects were detectable for 5-6 days in most cases, and even low doses (0.05g and 0.02g daily) showed significant effects.

Conclusions:

• The novel in vitro bleeding test (Thrombostat) is highly sensitive for monitoring aspirin's antiplatelet effects.
• This test can detect aspirin's impact even at low prophylactic doses.
• The Thrombostat assay is suitable for controlling low-dose aspirin therapy in preventing arterial thromboembolic disorders.